Moreover, four genes from the methionine metabolism gene set, such, AHCY, CBS, DNMT3A, and MTAP, are markers of poor prognosis for neuroblastoma and breast, but not for colon and lung, cancer patients. This evidence concerns the gene MTAP and neuroblastoma.